Independent fund research. Built on SEC filings.

How we research funds

ETF · Nasdaq-100 · Calamos

Calamos Nasdaq-100 Structured Alt Protection ETF - March (CPNM)

Ticker CPNM · · Holdings as of Jul 31, 2026

Expense ratio
0.69%$69/yr per $10k
Net assets
$14.8Mall share classes
Holdings
3

Bottom line

Is CPNM a good fund? The bottom line

CPNM is an actively managed Nasdaq-100 ETF from Calamos.

It charges 0.69% — about $69 a year on every $10,000 invested, cheaper than 53% of Nasdaq-100 funds we track.

With $14.8 million in net assets and 3 holdings, its largest position is Goldman Sachs & Co. LLC (109.7%) and the top 10 make up 99.3% of the portfolio.

What to watch

  • Concentrated: top 10 holdings are 99.3% of assets
  • Small fund ($14.8 million) — small funds are likelier to close

Updated Nov 19, 2026

What CPNM invests in

"Calamos Nasdaq-100 ? Structured Alt Protection ETF ? March (the ""Fund"") seeks to provide investment results that, before taking fees and expenses into account, match the positive price return of the Invesco QQQ Trust SM ?, Series 1 (""Underlying ETF"") up to a cap of 8.17% (the ""Cap""), while protecting against 100% of negative price return of the Underlying ETF (before fees and expenses), for the period from March 1, 2025 through February 28, 2026."

Each Funds prospectus contains one or more instances of a section titled Subsequent Outcome Periods. Each such section is hereby deleted in its entirety and replaced with the following: Approximately one week prior to the end of each Outcome Period, the Fund will file a prospectus supplement that will alert existing shareholders that the Outcome Period is approaching its conclusion and disclose the anticipated Cap range for the next Outcome Period. This filing will be mailed to existing shareholders. Following the close of business on the last day of the Outcome Period, the Fund will file a prospectus supplement that discloses the Funds Cap for the next Outcome Period. This filing will be mailed to existing shareholders. There is no guarantee the Cap will be within the anticipated Cap range. The information referenced above will also be available on the Funds website at www.calamos.com…

From the fund's prospectus (filed Jan 22, 2026).

What CPNM costs

On a $10,000 investment, CPNM's 0.69% expense ratio costs about $69 a year. The prospectus estimates $859 in total costs over 10 years (assuming 5% annual returns). The median Nasdaq-100 fund charges 0.77%.

See the full CPNM fee table →

CPNM top 10 holdings

#Holding% of fund
1Goldman Sachs & Co. LLC109.72%
2Goldman Sachs & Co. LLC3.22%
3Goldman Sachs & Co. LLC-13.67%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 99.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to CPNM

More funds like CPNM →

CPNM FAQ

What is the expense ratio of CPNM?
CPNM's expense ratio is 0.69%, which works out to about $69 a year for every $10,000 invested. The prospectus estimates total costs of $859 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CPNM a good investment?
It depends on your goals, but the data points to: concentrated: top 10 holdings are 99.3% of assets; small fund ($14.8 million) — small funds are likelier to close. This is general information, not personalized advice.
What does CPNM hold?
CPNM's largest holdings are Goldman Sachs & Co. LLC (109.7%), Goldman Sachs & Co. LLC (3.2%), Goldman Sachs & Co. LLC (-13.7%). It holds 3 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages CPNM?
CPNM is offered by Calamos through Calamos ETF Trust.